01 6Gamifant
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 54
2018 Revenue in Millions : 0
Growth (%) : New launch
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 73
2019 Revenue in Millions : 65
Growth (%) : 12
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 90
2020 Revenue in Millions : 67
Growth (%) : 38
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 84
2021 Revenue in Millions : 90
Growth (%) : -7
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 158
2022 Revenue in Millions : 84
Growth (%) : 84
Main Therapeutic Indication : Rare Diseases and Disorders
Currency : USD
2024 Revenue in Millions : 187
2023 Revenue in Millions : 158
Growth (%) : 19
